# Nuclide record f-18-florbetaben (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-florbetaben/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-florbetaben" ;
  schema:name "Florbetaben F-18"@en ;
  schema:alternateName "Neuraceq"@en, "Neuraceq" ;
  schema:description "A PET scan tracer that lights up amyloid plaques in the brain, helping doctors work out whether memory problems are due to Alzheimer's disease and whether the patient can have amyloid-lowering treatment."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-florbetaben/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/204677s041lbl.pdf>, <https://www.ema.europa.eu/en/medicines/human/EPAR/neuraceq>, <https://www.ema.europa.eu/system/files/documents/other/qualification-opinion-centiloid-measure-amyloid-pet-quantify-brain-amyloid-deposition-en.pdf>, <https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=308> ;
  nuclide:status "approved" ;
  nuclide:tag "amyloid PET", "diagnostic", "neurology" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 2014: PET imaging of the brain to estimate beta-amyloid neuritic plaque density in adults with cognitive impairment being evaluated for AD and other causes of cognitive decline", "EU 2014: PET imaging of beta-amyloid neuritic plaque density in adults with cognitive impairment being evaluated for Alzheimer's disease and other causes of cognitive impairment" ;
  nuclide:related <https://nuclide.cc/indications/alzheimers-disease/>, <https://nuclide.cc/drugs/f-18-florbetapir/>, <https://nuclide.cc/drugs/f-18-flutemetamol/>, <https://nuclide.cc/companies/lantheus/>, <https://nuclide.cc/isotopes/f-18/> .